Clinical Trial Update: Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial assessing pembrolizumab in combination with chemotherapy for advanced lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Lymphoma, Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN